Li Yan
Technik-/Wissenschafts-/F&E-Leiter bei Brii Biosciences Ltd.
Aktive Positionen von Li Yan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Li Yan
Ehemalige bekannte Positionen von Li Yan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRII BIOSCIENCES LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 02.04.2018 | 05.07.2023 |
| GSK PLC | Corporate Officer/Principal | - | - |
Ausbildung von Li Yan
| Peking University Health Science Center | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Statistik
International
| China | 3 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| GSK PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
